RVNC
Two Sigma Advisers’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,300
| Closed | -$26.5K | – | 2573 |
|
|
2024
Q2 | $26.5K | Buy |
+10,300
| New | +$26.5K | ﹤0.01% | 2391 |
|
|
2023
Q3 | – | Sell |
-1,124,000
| Closed | -$28.4M | – | 2615 |
|
|
2023
Q2 | $28.4M | Sell |
1,124,000
-425,500
| -27% | -$10.8M | 0.07% | 246 |
|
|
2023
Q1 | $49.9M | Buy |
1,549,500
+383,800
| +33% | +$12.4M | 0.13% | 165 |
|
|
2022
Q4 | $21.5M | Buy |
1,165,700
+658,200
| +130% | +$12.2M | 0.06% | 315 |
|
|
2022
Q3 | $13.7M | Buy |
507,500
+399,100
| +368% | +$10.8M | 0.04% | 414 |
|
|
2022
Q2 | $1.5M | Buy |
+108,400
| New | +$1.5M | ﹤0.01% | 1375 |
|
|
2020
Q4 | – | Sell |
-64,600
| Closed | -$1.62M | – | 2639 |
|
|
2020
Q3 | $1.62M | Buy |
64,600
+3,400
| +6% | +$85.5K | ﹤0.01% | 1272 |
|
|
2020
Q2 | $1.5M | Buy |
61,200
+11,600
| +23% | +$283K | ﹤0.01% | 1368 |
|
|
2020
Q1 | $734K | Buy |
+49,600
| New | +$734K | ﹤0.01% | 1633 |
|
|
2019
Q3 | – | Sell |
-16,600
| Closed | -$215K | – | 2427 |
|
|
2019
Q2 | $215K | Sell |
16,600
-19,600
| -54% | -$254K | ﹤0.01% | 2112 |
|
|
2019
Q1 | $571K | Buy |
+36,200
| New | +$571K | ﹤0.01% | 1741 |
|
|
2018
Q4 | – | Sell |
-19,000
| Closed | -$472K | – | 2490 |
|
|
2018
Q3 | $472K | Sell |
19,000
-22,306
| -54% | -$554K | ﹤0.01% | 1816 |
|
|
2018
Q2 | $1.13M | Buy |
41,306
+19,006
| +85% | +$522K | ﹤0.01% | 1563 |
|
|
2018
Q1 | $687K | Buy |
22,300
+12,700
| +132% | +$391K | ﹤0.01% | 1699 |
|
|
2017
Q4 | $343K | Buy |
+9,600
| New | +$343K | ﹤0.01% | 1899 |
|
|
2015
Q3 | – | Sell |
-9,800
| Closed | -$313K | – | 2017 |
|
|
2015
Q2 | $313K | Sell |
9,800
-16,700
| -63% | -$533K | ﹤0.01% | 1599 |
|
|
2015
Q1 | $549K | Buy |
+26,500
| New | +$549K | ﹤0.01% | 1303 |
|